Pieris Pharmaceuticals Stock Volatility
| PIRS Stock | USD 11.71 0.01 0.09% |
Pieris Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0628, which implies the firm had a -0.0628% return per unit of risk over the last 3 months. Pieris Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pieris Pharmaceuticals' Variance of 20.77, coefficient of variation of (12,636), and Risk Adjusted Performance of 0.0037 to confirm the risk estimate we provide. Key indicators related to Pieris Pharmaceuticals' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Pieris Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Pieris daily returns, and it is calculated using variance and standard deviation. We also use Pieris's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Pieris Pharmaceuticals volatility.
Pieris |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Pieris Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Pieris Pharmaceuticals at lower prices. For example, an investor can purchase Pieris stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Pieris Pharmaceuticals' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Pieris Pharmaceuticals Market Sensitivity And Downside Risk
Pieris Pharmaceuticals' beta coefficient measures the volatility of Pieris stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Pieris stock's returns against your selected market. In other words, Pieris Pharmaceuticals's beta of 0.87 provides an investor with an approximation of how much risk Pieris Pharmaceuticals stock can potentially add to one of your existing portfolios. Pieris Pharmaceuticals exhibits very low volatility with skewness of 2.4 and kurtosis of 11.61. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Pieris Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Pieris Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Pieris Pharmaceuticals Demand TrendCheck current 90 days Pieris Pharmaceuticals correlation with market (NYSE Composite)Pieris Beta |
Pieris standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 4.5 |
It is essential to understand the difference between upside risk (as represented by Pieris Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Pieris Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in pieris stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Pieris Pharmaceuticals.
Pieris Pharmaceuticals Stock Volatility Analysis
Volatility refers to the frequency at which Pieris Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Pieris Pharmaceuticals' price changes. Investors will then calculate the volatility of Pieris Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Pieris Pharmaceuticals' volatility:
Historical Volatility
This type of stock volatility measures Pieris Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Pieris Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Pieris Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Pieris Pharmaceuticals' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pieris Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Pieris Pharmaceuticals Projected Return Density Against Market
Given the investment horizon of 90 days Pieris Pharmaceuticals has a beta of 0.871 indicating Pieris Pharmaceuticals market returns are related to returns on the market. As the market goes up or down, Pieris Pharmaceuticals is expected to follow.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pieris Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pieris Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pieris stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Pieris Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Predicted Return Density |
| Returns |
What Drives a Pieris Pharmaceuticals Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Pieris Pharmaceuticals Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Pieris Pharmaceuticals is -1591.18. The daily returns are distributed with a variance of 20.23 and standard deviation of 4.5. The mean deviation of Pieris Pharmaceuticals is currently at 2.89. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.62
α | Alpha over NYSE Composite | -0.12 | |
β | Beta against NYSE Composite | 0.87 | |
σ | Overall volatility | 4.50 | |
Ir | Information ratio | -0.03 |
Pieris Pharmaceuticals Stock Return Volatility
Pieris Pharmaceuticals historical daily return volatility represents how much of Pieris Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 4.4975% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.6379% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Pieris Pharmaceuticals Volatility
Volatility is a rate at which the price of Pieris Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Pieris Pharmaceuticals may increase or decrease. In other words, similar to Pieris's beta indicator, it measures the risk of Pieris Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Pieris Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Market Cap | 13.2 B | 13.9 B |
Pieris Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Pieris Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Pieris Pharmaceuticals' price varies over time.
3 ways to utilize Pieris Pharmaceuticals' volatility to invest better
Higher Pieris Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Pieris Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Pieris Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Pieris Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Pieris Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Pieris Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Pieris Pharmaceuticals Investment Opportunity
Pieris Pharmaceuticals has a volatility of 4.5 and is 7.03 times more volatile than NYSE Composite. Compared to the overall equity markets, volatility of historical daily returns of Pieris Pharmaceuticals is lower than 39 percent of all global equities and portfolios over the last 90 days. You can use Pieris Pharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend and little activity. Check odds of Pieris Pharmaceuticals to be traded at $11.59 in 90 days.Average diversification
The correlation between Pieris Pharmaceuticals and NYA is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and NYA in the same portfolio, assuming nothing else is changed.
Pieris Pharmaceuticals Additional Risk Indicators
The analysis of Pieris Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Pieris Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Pieris Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0037 | |||
| Market Risk Adjusted Performance | (0.04) | |||
| Mean Deviation | 3.02 | |||
| Coefficient Of Variation | (12,636) | |||
| Standard Deviation | 4.56 | |||
| Variance | 20.77 | |||
| Information Ratio | (0.03) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pieris Pharmaceuticals Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Pieris Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Pieris Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Pieris Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Pieris Pharmaceuticals.
When determining whether Pieris Pharmaceuticals is a strong investment it is important to analyze Pieris Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pieris Pharmaceuticals' future performance. For an informed investment choice regarding Pieris Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pieris Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pieris Stock please use our How to Invest in Pieris Pharmaceuticals guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Pieris Stock analysis
When running Pieris Pharmaceuticals' price analysis, check to measure Pieris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pieris Pharmaceuticals is operating at the current time. Most of Pieris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pieris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pieris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pieris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Pieris Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pieris Pharmaceuticals. If investors know Pieris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pieris Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (21.60) | Revenue Per Share 38.026 | Quarterly Revenue Growth (0.78) | Return On Assets (0.15) | Return On Equity (0.90) |
The market value of Pieris Pharmaceuticals is measured differently than its book value, which is the value of Pieris that is recorded on the company's balance sheet. Investors also form their own opinion of Pieris Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pieris Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pieris Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pieris Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pieris Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pieris Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pieris Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.